Abstract
Biopolymers and their composites have been extensively investigated in recent years for multiple applications, especially in environmental, medical, and pharmaceutical fields. Bacterial cellulose (BC) has emerged as a novel biomaterial owing to its nontoxic, high-liquid absorbing and holding capacity, drug-carrying ability, and pollutant absorbing features. Additionally, its web-shaped three-dimensional (3D) structure and hydrogen bonding sites have incited a combination of various nanoparticles, polymers, and other materials with BC in the form of composites. Such BC-based composites have been developed through in-situ, ex-situ, and solution casting methods for targeted applications, such as air and water filters, controlled drug delivery systems, wound dressing materials, and tissue regeneration. This review details the production and development of BCbased composites with different materials and by various methods. It further describes various applications of BC-based composites in the environmental and pharmaceutical sectors, with specific examples from the recent literature. This review could potentially appeal a wide readership in these two emerging fields, where novel and advanced materials for different applications have been developed on a regular basis using BC as the base material.
Keywords: Bacterial cellulose, production, composites, environmental applications, pharmaceutical applications, tissue regeneration.
Current Pharmaceutical Design
Title:Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors
Volume: 26 Issue: 45
Author(s): Mazhar Ul-Islam, Salman Ul-Islam, Sumayia Yasir, Atiya Fatima, Md. Wasi Ahmed, Young Sup Lee, Sehrish Manan and Muhammad Wajid Ullah*
Affiliation:
- Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan 430074,China
Keywords: Bacterial cellulose, production, composites, environmental applications, pharmaceutical applications, tissue regeneration.
Abstract: Biopolymers and their composites have been extensively investigated in recent years for multiple applications, especially in environmental, medical, and pharmaceutical fields. Bacterial cellulose (BC) has emerged as a novel biomaterial owing to its nontoxic, high-liquid absorbing and holding capacity, drug-carrying ability, and pollutant absorbing features. Additionally, its web-shaped three-dimensional (3D) structure and hydrogen bonding sites have incited a combination of various nanoparticles, polymers, and other materials with BC in the form of composites. Such BC-based composites have been developed through in-situ, ex-situ, and solution casting methods for targeted applications, such as air and water filters, controlled drug delivery systems, wound dressing materials, and tissue regeneration. This review details the production and development of BCbased composites with different materials and by various methods. It further describes various applications of BC-based composites in the environmental and pharmaceutical sectors, with specific examples from the recent literature. This review could potentially appeal a wide readership in these two emerging fields, where novel and advanced materials for different applications have been developed on a regular basis using BC as the base material.
Export Options
About this article
Cite this article as:
Ul-Islam Mazhar , Ul-Islam Salman , Yasir Sumayia, Fatima Atiya , Ahmed Wasi Md. , Lee Sup Young, Manan Sehrish and Ullah Wajid Muhammad *, Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors, Current Pharmaceutical Design 2020; 26 (45) . https://dx.doi.org/10.2174/1381612826666201008165241
DOI https://dx.doi.org/10.2174/1381612826666201008165241 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Food-derived bioactive peptides against chronic diseases
Chronic diseases, such as cardiovascular diseases and metabolic diseases, have become a great threat to the human health in recent decades due to the excessive food consumption and the prevalence of sedentary lifestyle. As a class of natural compounds, food-derived bioactive peptides have been demonstrated to possess great potential for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets MicroRNA-155 Functions as a Negative Regulator of RhoA Signaling in TGF-β-induced Endothelial to Mesenchymal Transition
MicroRNA Cutaneous Markers of HIV Infection and Progression
Current HIV Research Molecular Targets for Papillomavirus Therapy
Current Drug Targets - Infectious Disorders Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Experimental Animal Models for Preclinical Investigation of the Bladder Cancer
New Emirates Medical Journal High Throughput Screening of Normal and Neoplastic Tissue Samples
Combinatorial Chemistry & High Throughput Screening Clinical Usefulness of Abbreviated MRI Protocol in Breast Cancer Detection
Current Medical Imaging New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies
Current Medicinal Chemistry Regulation and Effect of Telomerase and Telomeric Length in Stem Cells
Current Stem Cell Research & Therapy Apoptosis Induced by Topoisomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Nano-soldiers Ameliorate Silibinin Delivery: A Review Study
Current Drug Delivery Translocator Protein (TSPO) in Breast Cancer
Current Molecular Medicine Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Evolution and Pathogenesis of Oncoviruses Associated with Head and Neck Cancer: History and Current Concepts
Recent Patents on Biomarkers The Targets of Curcumin
Current Drug Targets Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Current Pharmaceutical Design Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Recent Advances in Pretargeted Radioimmunotherapy
Current Medicinal Chemistry